Cardiff Oncology (CRDF) Stock: Buy, Sell, or Hold?
CRDF - Cardiff Oncology, Inc. Common Stock
$0.95
0.01 (1.45%)
▲
5d:
-2.92%
30d:
-28.95%
90d:
+12.76%
WAIT
LOW Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Nov 05, 2026
14d
Get Alerted When CRDF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRDF shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRDF shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRDF is currently trading at $0.94, which is considered oversold relative to its 30-day fair value range of $1.00 to $1.30.
Technical Outlook: Technically, CRDF is in a strong downtrend. Immediate support is located at $0.88, while resistance sits at $1.13.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.81 (+524.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRDF is in a strong downtrend. Immediate support is located at $0.88, while resistance sits at $1.13.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.81 (+524.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.00 -
$1.30
Company Quality Score
52/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 524.2% below Wall St target ($5.81)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.00 -
$1.30
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.22
(23.7%)
Support & Resistance Levels
Support Level
$0.88
Resistance Level
$1.13
Current Trend
Strong Downtrend
Technical data as of
Oct 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.74
Wall Street Target
$5.81
(+524.2%)
Revenue Growth (YoY)
-14.1%
Share & Embed Analysis
Last updated: October 21, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
Data refreshes hourly during market hours. Next update: 11:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 56 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 62 BUY |
|
TRVI
Trevi Therapeutics Inc |
STRONG BUY
11 analysts |
$28 | 66 BUY |
